Burlington Drug Co
Burlington Drug Co is a privately held US pharmaceutical wholesaler that distributes brand, generic, and specialty medications, OTC products, and HME to independent community and long-term care pharmacies in the Southeast US via multiple regional distribution centers, a customer portal, and dedicated field representatives.
- Company typePrivate
- Founded1944
- HeadquartersMilton, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Burlington Drug Co does
Burlington Drug Co operates as a pharmaceutical wholesaler serving independent community pharmacies and long-term care pharmacies in the United States. Based on the available firmographic and operational data, the company's offering centers on wholesale distribution of brand and generic pharmaceuticals, specialty medications, OTC products, and home medical equipment (HME), executed through state-of-the-art distribution centers that ship thousands of orders nightly. Customers are SMB independent pharmacy operators, with no disclosed chain or enterprise accounts; relationships are described as generational and supported by dedicated field representatives plus inside sales and customer service staff co-located at each distribution center.
The company's technology surface consists of a web-based customer portal (eGate) for order management, updates, and industry news, and a solutions platform branded as PharmacyFocus that bundles tools, merchandising guidance, and operational support for independent pharmacy owners. A differentiated Disaster Response Team provides emergency delivery during hurricanes and severe weather, framed as a service differentiator when standard carriers are unable to operate. The company holds NABP Accredited Drug Distributor certification and is listed in the Pharmacy 500.
The revenue model is wholesale product resale to pharmacy customers via direct field sales and inside sales motions, with quote-based (non-publicly-disclosed) pricing negotiated per account through the representative. GTM is sales-led, emphasizing personalized service, partner-with-us enrollment, and local relationship management rather than digital self-service acquisition. Operating geography is the Southeast US across multiple regional distribution centers. The company is privately held with no public ticker, parent company, or institutional ownership disclosed in the source material.
Note on data: the detailed product, technology, customer, and operational records reference "Smith Drug Company" (Spartanburg, SC, founded 1944) while firmographic records name "Burlington Drug Co" (Milton, US, founded 1891, 11-50 employees). This conflict has been resolved in favor of the firmographic name Burlington Drug Co as the primary subject; the detailed operational profile reflects what the source material describes.
Burlington Drug Co firmographics
Firmographics- Name
- Burlington Drug Co
- Legal name
- Smith Drug Company
- Website
- https://burlingtondrug.com
- Company type
- Private
- Founded year
- 1944
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Burlington Drug Co is a privately held US pharmaceutical wholesaler that distributes brand, generic, and specialty medications, OTC products, and HME to independent community and long-term care pharmacies in the Southeast US via multiple regional distribution centers, a customer portal, and dedicated field representatives.
- Ownership category
- akta.pro rank
Burlington Drug Co industry classification
Industry- Product category
- Pharmaceutical Distribution
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)
- akta.pro secondary industry
- Specialty Pharmacy & Biologics Distribution (CRAOAHAD)
Keywords
Where Burlington Drug Co is headquartered
LocationHeadquarters
- HQ city
- Milton
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Burlington Drug Co business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Distribution: Smith Drug Company generates revenue through wholesale distribution of pharmaceuticals to independent retail and long-term care pharmacies. They offer an extensive assortment of products including specialty medications, OTC, HME, brand and generic pharmaceuticals. Revenue comes from product sales to pharmacy customers with whom they have built relationships lasting generations.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Burlington Drug Co product offering
Product offeringCore offering
Burlington Drug Co operates as a pharmaceutical wholesaler distributing brand and generic pharmaceuticals, specialty medications, OTC products, and HME (Home Medical Equipment) to independent retail and long-term care pharmacies across the United States. The company operates state-of-the-art distribution centers that ship thousands of orders every night with high accuracy, supported by an eGate customer portal for orders and updates and a PharmacyFocus solutions platform. A dedicated Disaster Response Team delivers regular orders and emergency supplies during hurricanes and severe weather events.
Product overview
Smith Drug Company is a pharmaceutical wholesaler offering a single integrated platform focused on independent community pharmacy and long term care pharmacy. The core product is their pharmaceutical distribution service, supported by the Customer Portal (web-based resource for orders, updates, and industry news), PharmacyFocus solutions module, and Disaster Response Services. Their state-of-the-art distribution centers process thousands of orders nightly, offering specialty medications, OTC products, HME, and brand and generic pharmaceuticals. The company emphasizes customer service through local representatives and IT support.
Differentiator
Problem solved
Functional benefit
Brands
- PharmacyFocus: A solution/portal offering mentioned on the website for pharmacy services.
Products and services
- Pharmaceutical Distribution Services Full-service pharmaceutical wholesale distribution providing brand and generic pharmaceuticals, specialty medications, OTC products, and HME (Home Medical Equipment) to independent retail and long-term care pharmacies through company-owned distribution centers.
- Customer Portal (eGate) Web-based self-serve portal (egate.smithdrug.com) enabling customers to place orders, manage accounts, view updates, and access industry news related to their pharmaceutical distribution.
- PharmacyFocus Solutions offering designed to help independent community pharmacies and long-term care pharmacies optimize operations and improve patient outcomes through tools, products, and services.
- Disaster Response Services Emergency delivery services and dedicated disaster response team delivering regular orders and emergency supplies to pharmacy customers during catastrophes such as hurricanes and severe weather.
Companies that use Burlington Drug Co
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Burlington Drug Co technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Burlington Drug Co partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights3 records
Burlington Drug Co competitors and assessment
Company assessmentDirect peers
- Anda Inc: Anda, a Teva subsidiary, distributes generic, brand, and specialty pharmaceuticals to retail pharmacies and pharmacy chains. It competes directly with Smith Drug for independent pharmacy distribution volume, particularly in generics and specialty categories.
- Morris & Dickson: Morris & Dickson is one of the largest U.S. pharmaceutical wholesalers exclusively serving independent retail and LTC pharmacies — the closest direct peer to Smith Drug Company in terms of customer focus, product mix (brand, generic, specialty, HME), and value proposition.
- North Carolina Mutual Drug: Mutual Drug is a cooperatively-owned pharmaceutical wholesaler focused on independent pharmacies across the Southeast U.S. — closely comparable to Smith Drug in customer base (independents), geography, and full-line distribution model including specialty and LTC.
Broad incumbents
- Cencora (formerly AmerisourceBergen): Cencora is one of the 'Big 3' U.S. pharmaceutical wholesalers with broad retail, health-system, and specialty distribution. Its World Courier/PharmaLex businesses and scale make it a powerful competitive incumbent that Smith Drug must position against on service and reliability.
- Cardinal Health: Cardinal Health is the third 'Big 3' U.S. pharmaceutical wholesaler, with extensive retail pharmacy, hospital, and at-home solutions. Its scale and integrated services (including its recent specialty aggregation strategy) represent the upper bound of competitive pressure on Smith Drug.
- McKesson Corporation: McKesson is one of the 'Big 3' full-line pharmaceutical distributors in the U.S. and the dominant player in wholesale drug distribution. It competes with Smith Drug for large chain and health-system accounts, and indirectly for independent pharmacy volume via scale-driven pricing.
Emerging players
- TopRx: TopRx is a growing specialty pharmaceutical distributor serving independent pharmacies, with a focus on limited-distribution drugs and patient Hub services. It overlaps with Smith Drug's specialty distribution franchise but is earlier-stage and more narrowly focused.
Regional players
- R&S Drug Distribution (R&S Northeast): R&S Drug Distribution is a regional full-line pharmaceutical wholesaler serving independent pharmacies in the Northeast U.S. It is comparable to Smith Drug in customer focus and product mix but operates in a different geographic territory.
Others
- ClarusONE Sourcing Services: ClarusONE is a generic pharmaceutical sourcing joint venture between Walmart and McKesson. While not a direct competitor to Smith Drug, it shapes the generic procurement landscape that independent pharmacies and their wholesalers must navigate.
- PharmaLex / Direct Rx: Specialty pharmacy and limited-distribution drug service providers adjacent to Smith Drug's specialty medication offering. Comparable as ecosystem participants in the specialty distribution channel serving independent and LTC pharmacies.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Burlington Drug Co social profiles
Digital presenceBurlington Drug Co compliance and trust
Trust signalCompliance1 record
Burlington Drug Co financial estimates
Financial estimateRevenue estimate
Valuation estimate
Burlington Drug Co leadership team
Management profileNumber of profiles
Burlington Drug Co funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Burlington Drug Co M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Burlington Drug Co
What does Burlington Drug Co do?
Burlington Drug Co operates as a pharmaceutical wholesaler distributing brand and generic pharmaceuticals, specialty medications, OTC products, and HME (Home Medical Equipment) to independent retail and long-term care pharmacies across the United States. The company operates state-of-the-art distribution centers that ship thousands of orders every night with high accuracy, supported by an eGate customer portal for orders and updates and a PharmacyFocus solutions platform. A dedicated Disaster Response Team delivers regular orders and emergency supplies during hurricanes and severe weather events.
Is Burlington Drug Co a public or private company?
Burlington Drug Co is a private company. It is classified as unknown and is currently operating.
When was Burlington Drug Co founded?
Burlington Drug Co was founded in 1944. It employs 11 to 50 people.
Where is Burlington Drug Co based?
Burlington Drug Co is headquartered in Milton, United States, in the North America region.
How does Burlington Drug Co make money?
One revenue line is on record: pharmaceutical Distribution.
Who are Burlington Drug Co's main competitors?
Direct peers on record are Anda Inc, Morris & Dickson and North Carolina Mutual Drug. Broad incumbents are Cencora (formerly AmerisourceBergen), Cardinal Health and McKesson Corporation. TopRx is listed as an emerging player. R&S Drug Distribution (R&S Northeast) is listed as a regional player. Others are ClarusONE Sourcing Services and PharmaLex / Direct Rx.
Does Burlington Drug Co have an API?
No public API is recorded for Burlington Drug Co.
What industry is Burlington Drug Co in?
Burlington Drug Co's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution, with a secondary code of CRAOAHAD, Specialty Pharmacy & Biologics Distribution. Its SIC code is 5047.